Covaxin (development name, BBV152) is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council...

Dogra Gupta. The SARS-CoV-2 strain (NIV-2020-770) used in developing the BBV152 vaccine is retrieved from tourists who arrive in New Delhi, India. The scientific...

- University of Oxford’s AZD1222 (marketed as Covishield in India) and BBV152 (marketed as Covaxin, developed in India by Bharat Biotech in association...

000 participants. BBIBP-CorV shares similar technology with CoronaVac and BBV152, other inactivated virus vaccines for COVID-19. Peer-reviewed results published...

the Serum Institute of India (SII) under the trade name "Covishield", and BBV152 (Covaxin), a vaccine developed by Bharat Biotech in association with the...

It has a shelf life of at least six months. Covaxin On January 2, 2021, BBV152 (marketed as Covaxin), first indigenous vaccine, developed by Bharat Biotech...

Biotech/Indian Council of Medical Research Completed Bharat Biotech's Covaxin (BBV152) is an inactivated COVID-19 vaccine that uses adjuvant Alhydroxiquim-II...

doi:10.1038/s41573-021-00163-y. PMC 8023785. PMID 33824489. "COVAXIN® (BBV152) – Inactivated, COVID-19 vaccine". www.who.int. Retrieved 2024-07-14. Soni...

world, and their joint product was mostly referred to simply as 'Pfizer'. BBV152 CureVac Moderna COVID-19 vaccine Novavax COVID-19 vaccine Oxford–AstraZeneca...

Federal Audit Court and the Federal Public Prosecutor's Office. Covaxin (or BBV152) is a vaccine against COVID-19 produced in India by the Bharat Biotech laboratory...